Heterozygous HNRNPU variants cause early onset epilepsy and severe intellectual disability
- PMID: 28393272
- DOI: 10.1007/s00439-017-1795-6
Heterozygous HNRNPU variants cause early onset epilepsy and severe intellectual disability
Abstract
Pathogenic variants in genes encoding subunits of the spliceosome are the cause of several human diseases, such as neurodegenerative diseases. The RNA splicing process is facilitated by the spliceosome, a large RNA-protein complex consisting of small nuclear ribonucleoproteins (snRNPs), and many other proteins, such as heterogeneous nuclear ribonucleoproteins (hnRNPs). The HNRNPU gene (OMIM *602869) encodes the heterogeneous nuclear ribonucleoprotein U, which plays a crucial role in mammalian development. HNRNPU is expressed in the fetal brain and adult heart, kidney, liver, brain, and cerebellum. Microdeletions in the 1q44 region encompassing HNRNPU have been described in patients with intellectual disability (ID) and other clinical features, such as seizures, corpus callosum abnormalities (CCA), and microcephaly. Recently, pathogenic HNRNPU variants were identified in large ID and epileptic encephalopathy cohorts. In this study, we provide detailed clinical information of five novels and review two of the previously published individuals with (likely) pathogenic de novo variants in the HNRNPU gene including three non-sense and two missense variants, one small intragenic deletion, and one duplication. The phenotype in individuals with variants in HNRNPU is characterized by early onset seizures (6/7), severe ID (6/6), severe speech impairment (6/6), hypotonia (6/7), and central nervous system (CNS) (5/6), cardiac (4/6), and renal abnormalities (3/4). In this study, we broaden the clinical and mutational HNRNPU-associated spectrum, and demonstrate that heterozygous HNRNPU variants cause epilepsy, severe ID with striking speech impairment and variable CNS, cardiac, and renal anomalies.
Similar articles
-
Molecular characterization of 1q44 microdeletion in 11 patients reveals three candidate genes for intellectual disability and seizures.Am J Med Genet A. 2012 Jul;158A(7):1633-40. doi: 10.1002/ajmg.a.35423. Epub 2012 Jun 7. Am J Med Genet A. 2012. PMID: 22678713
-
An episode of acute encephalopathy with biphasic seizures and late reduced diffusion followed by hemiplegia and intractable epilepsy observed in a patient with a novel frameshift mutation in HNRNPU.Brain Dev. 2018 Oct;40(9):813-818. doi: 10.1016/j.braindev.2018.05.010. Epub 2018 May 29. Brain Dev. 2018. PMID: 29858110
-
Expanding the phenotype of HNRNPU-related neurodevelopmental disorder with emphasis on seizure phenotype and review of literature.Am J Med Genet A. 2022 May;188(5):1497-1514. doi: 10.1002/ajmg.a.62677. Epub 2022 Feb 9. Am J Med Genet A. 2022. PMID: 35138025 Free PMC article. Review.
-
Clinical and molecular characterization of de novo loss of function variants in HNRNPU.Am J Med Genet A. 2017 Oct;173(10):2680-2689. doi: 10.1002/ajmg.a.38388. Epub 2017 Aug 16. Am J Med Genet A. 2017. PMID: 28815871
-
Clinical findings of 21 previously unreported probands with HNRNPU-related syndrome and comprehensive literature review.Am J Med Genet A. 2020 Jul;182(7):1637-1654. doi: 10.1002/ajmg.a.61599. Epub 2020 Apr 22. Am J Med Genet A. 2020. PMID: 32319732 Review.
Cited by
-
Precision Medicine: from Molecular Diagnoses to Treatment Opportunities in Medical Genetics.Mol Syndromol. 2021 Apr;12(2):65-68. doi: 10.1159/000515363. Epub 2021 Apr 12. Mol Syndromol. 2021. PMID: 34012375 Free PMC article. No abstract available.
-
An epilepsy-associated mutation in the nuclear import receptor KPNA7 reduces nuclear localization signal binding.Sci Rep. 2020 Mar 16;10(1):4844. doi: 10.1038/s41598-020-61369-5. Sci Rep. 2020. PMID: 32179771 Free PMC article.
-
Novel Genetic and Phenotypic Expansion in Ameliorated PUF60-Related Disorders.Int J Mol Sci. 2024 Feb 8;25(4):2053. doi: 10.3390/ijms25042053. Int J Mol Sci. 2024. PMID: 38396730 Free PMC article.
-
Missense variants in TAF1 and developmental phenotypes: challenges of determining pathogenicity.Hum Mutat. 2019 Oct 23:10.1002/humu.23936. doi: 10.1002/humu.23936. Online ahead of print. Hum Mutat. 2019. PMID: 31646703 Free PMC article.
-
Neurodevelopmental deficits and cell-type-specific transcriptomic perturbations in a mouse model of HNRNPU haploinsufficiency.PLoS Genet. 2023 Oct 2;19(10):e1010952. doi: 10.1371/journal.pgen.1010952. eCollection 2023 Oct. PLoS Genet. 2023. PMID: 37782669 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical